Current clinical trials of 17-AAG and 17-DMAG - Referral resource

被引：0
|
作者：
Ivy, PS [1 ]
Schoenfeldt, M
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] Emmes Corp, Rockville, MD USA
来源：
ONCOLOGY-NEW YORK | 2004年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：610 / 610
页数：1
相关论文
共 50 条
  • [21] Concurrent delivery of paclitaxel and 17-AAG via micellar nanocarriers
    Katragadda, Usha
    Fan, Wei
    Tan, Chalet
    CANCER RESEARCH, 2012, 72
  • [22] Imatinib in combination with 17-allylamino-17-demethoxy-geldanamycin (17-AAG) for treatment of chronic myelogenous leukemia
    Topaly, J
    Schad, M
    Zeller, W
    Fruehauf, S
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 72 - 72
  • [23] In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative
    Hollingshead, M
    Alley, M
    Burger, AM
    Borgel, S
    Pacula-Cox, C
    Fiebig, HH
    Sausville, EA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (02) : 115 - 125
  • [24] In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative
    Melinda Hollingshead
    Michael Alley
    Angelika M. Burger
    Suzanne Borgel
    Christine Pacula-Cox
    Heinz-Herbert Fiebig
    Edward A. Sausville
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 115 - 125
  • [25] Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1:: Role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
    Guo, WC
    Reigan, P
    Siegel, D
    Zirrolli, J
    Gustafson, D
    Ross, D
    CANCER RESEARCH, 2005, 65 (21) : 10006 - 10015
  • [26] Effects of the inhibition of NPM-ALK kinase activity by 17-allylamino-17-demethoxygeldanamycin (17-AAG).
    Turturro, F
    Frist, AY
    Arnold, MD
    BLOOD, 2001, 98 (11) : 465A - 465A
  • [27] 17-AAG特异的细胞毒作用
    林胜利
    生理科学进展, 2004, (02) : 124 - 124
  • [28] 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WTB-Raf -: Expressing uveal melanoma cell lines
    Babchia, Narjes
    Calipel, Armelle
    Mouriaux, Frederic
    Faussat, Anne-Marie
    Mascarelli, Frederic
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (06) : 2348 - 2356
  • [29] Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL - Inhibition of P-glycoprotein function by 17-AAG
    Radujkovic, A
    Schad, M
    Topaly, J
    Veldwijk, MR
    Laufs, S
    Schultheis, BS
    Jauch, A
    Melo, JV
    Fruehauf, S
    Zeller, WJ
    LEUKEMIA, 2005, 19 (07) : 1198 - 1206
  • [30] Toxicity studies with 17-(Dimethylaminoethylamino)-17-demethoxygeldamnycin (17-DMAG; NSC-707545) in rats and dogs.
    Glaze, ER
    Lambert, AL
    Page, J
    Egorin, M
    Eiseman, J
    Holleran, J
    Tomaszewski, JE
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6215S - 6215S
12345